Investing

As Warren Buffett prepares to kick off Berkshire Hathaway’s annual shareholder meeting, the absence of his longtime partner, Charlie Munger, looms large. Munger’s recent passing has left a void that will undoubtedly be felt by the thousands of shareholders who attend the event, which has been described as “Woodstock for Capitalists.” The meeting, which will
0 Comments
Amazon.com recently reported quarterly results that surpassed Wall Street’s expectations. The company’s focus on artificial intelligence has been a significant factor in driving growth in its cloud-computing division. Despite the impressive performance, Amazon’s current-quarter revenue forecast fell short of expectations, causing a slight dip in the stock price during the regular session. Chief Financial Officer
0 Comments
Amazon recently reported its first-quarter earnings, surpassing expectations with both its earnings per share and revenue figures. The company’s revenue of $143.3 billion exceeded the forecasted $142.5 billion, while its earnings per share of 98 cents outperformed the expected 83 cents. The stock market reacted positively to the news, with Amazon’s stock price rising during
0 Comments
In a recent interview with CNBC’s “ETF Edge,” Brett Winton, the chief futurist at ARK Invest, highlighted five technological areas that he believes will give tech investors an edge in the market. These areas include robotics, artificial intelligence, multi-omics sequencing, public blockchain, and energy storage. Winton emphasized that these sectors are all entering the marketplace
0 Comments
The Food and Drug Administration’s recent announcement approving Pfizer’s treatment for hemophilia B marks a significant milestone in the field of gene therapy. The drug, known as Beqvez, is the first gene therapy from Pfizer to receive clearance in the U.S., offering new hope for adults with moderate to severe hemophilia B. Beqvez is a
0 Comments
Walgreens recently announced its plans to partner directly with drugmakers to provide cell and gene therapies to patients in the United States. This initiative is part of a broader expansion of the company’s specialty pharmacy services. The establishment of a new business unit dedicated to the specialty pharmacy segment, which includes AllianceRx as a subsidiary,
0 Comments
Amidst the ongoing Q4 FY24 earnings season, Goldman Sachs analysts have conducted a thorough recalibration of their projections for the Indian pharmaceutical sector. This recalibration takes into account a wide spectrum of variables, ranging from monthly sales data to currency fluctuations. One of the key observations made by the analysts is that the sector is
0 Comments
The uber wealthy live in a world apart, with investing strategies that set them apart from the average investor. According to Kevin Teng, CEO of WRISE Wealth Management Singapore, individuals with a total net worth of over $100 million are considered part of the 0.001% club of centimillionaires. Globally, there are around 28,420 centimillionaires, and
0 Comments
Amid macroeconomic concerns and geopolitical tensions, investors are searching for stable investment options. One of the most favored choices amongst Wall Street analysts is Enterprise Products Partners (EPD), a midstream energy services provider. This limited partnership has consistently increased its cash distribution for 25 years, with a compound annual growth rate of 7%. With a
0 Comments